The number of detections of illegal border crossings along the EU’s external borders fell 13% last year to around 124 000, in large part due to the impact of COVID-19 restrictions put in place by various countries, according to preliminary figures collected by Frontex. This was the lowest number of illegal border crossings since 2013. […]
The University of Almeria, the first Andalusian university and the second in Spain to obtain certification from AENOR’s COVID-19
19, the first university in Andalusia and the second in Spain to achieve such a prestigious certification, demonstrating its total commitment to the protection of students, PAS and PDI. With great satisfaction the Management of the University of Almeria has received the notification coming from AENOR: it has been granted the Certification of Protocols in […]
EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca
EMA has received an application for conditional marketing authorisation (CMA) for a COVID-19 vaccine developed by AstraZeneca and Oxford University. The assessment of the vaccine, known as COVID-19 Vaccine AstraZeneca, will proceed under an accelerated timeline. An opinion on the marketing authorisation could be issued by 29 January during the meeting of EMA’s scientific committee for human […]
European Commission authorises second safe and effective vaccine against COVID-19
The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Moderna, the second COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency (EMA) and is endorsed […]
European Commission authorises first safe and effective vaccine against COVID-19
The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by BioNTech and Pfizer, making it the first COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency […]
Waging war against SARS-CoV-2 with Europe’s most powerful supercomputers
Searching for new COVID-19 treatments, an EU-funded project conducted a supercomputing experiment to study the interaction of over 70 billion antiviral molecules with SARS-CoV-2 proteins. A huge molecular computation experiment was recently conducted to identify new treatments against the SARS-CoV-2 virus. Run by the EU-funded EXSCALATE4CoV project, the experiment is believed to be the most […]
Commission approves contract with Moderna to ensure access to a potential vaccine
The European Commission approved a sixth contract under the EU Vaccines Strategy, this time with the pharmaceutical company Moderna. The contract provides for the initial purchase of 80 million doses on behalf of all EU Member States, plus an option to request up to a further 80 million doses, to be supplied once a vaccine […]